BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36090803)

  • 1. Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience.
    Del Baldo G; Carai A; Abbas R; Cacchione A; Vinci M; Di Ruscio V; Colafati GS; Rossi S; Diomedi Camassei F; Maestro N; Temelso S; Pericoli G; De Billy E; Giovannoni I; Carboni A; Rinelli M; Agolini E; Mackay A; Jones C; Chiesa S; Balducci M; Locatelli F; Mastronuzzi A
    Ther Adv Med Oncol; 2022; 14():17588359221113693. PubMed ID: 36090803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma.
    Özkan A; Yağcı Küpeli B; Küpeli S; Sezgin G; Bayram İ
    Childs Nerv Syst; 2024 Jun; 40(6):1671-1680. PubMed ID: 38478066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
    Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
    Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.
    Kebudi R; Cakir FB; Bay SB; Gorgun O; Altınok P; Iribas A; Agaoglu FY; Darendeliler E
    Childs Nerv Syst; 2019 Jan; 35(1):83-89. PubMed ID: 30417211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single institution experience in re-irradiation of biopsy-proven diffuse intrinsic pontine gliomas.
    Zamora PL; Miller SR; Kovoor JJ
    Childs Nerv Syst; 2021 Aug; 37(8):2539-2543. PubMed ID: 33973056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report.
    DeWire M; Lazow M; Campagne O; Leach J; Fuller C; Senthil Kumar S; Stanek J; de Blank P; Hummel TR; Pillay-Smiley N; Salloum R; Stevenson CB; Baxter P; Gass D; Goldman S; Leary SES; Carle A; Mikael L; Crabtree D; Chaney B; Lane A; Drissi R; Stewart CF; Fouladi M
    Neurooncol Adv; 2022; 4(1):vdac055. PubMed ID: 35611273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric diffuse intrinsic pontine glioma: where do we stand?
    Rashed WM; Maher E; Adel M; Saber O; Zaghloul MS
    Cancer Metastasis Rev; 2019 Dec; 38(4):759-770. PubMed ID: 31802357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
    DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
    J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
    Crotty EE; Leary SES; Geyer JR; Olson JM; Millard NE; Sato AA; Ermoian RP; Cole BL; Lockwood CM; Paulson VA; Browd SR; Ellenbogen RG; Hauptman JS; Lee A; Ojemann JG; Vitanza NA
    J Neurooncol; 2020 Jul; 148(3):607-617. PubMed ID: 32556862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Insights into Diffuse Intrinsic Pontine Glioma.
    Lapin DH; Tsoli M; Ziegler DS
    Front Oncol; 2017; 7():57. PubMed ID: 28401062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study.
    Fleischhack G; Massimino M; Warmuth-Metz M; Khuhlaeva E; Janssen G; Graf N; Rutkowski S; Beilken A; Schmid I; Biassoni V; Gorelishev SK; Kramm C; Reinhard H; Schlegel PG; Kortmann RD; Reuter D; Bach F; Iznaga-Escobar NE; Bode U
    J Neurooncol; 2019 May; 143(1):107-113. PubMed ID: 30830679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketogenic diet treatment in diffuse intrinsic pontine glioma in children: Retrospective analysis of feasibility, safety, and survival data.
    Perez A; van der Louw E; Nathan J; El-Ayadi M; Golay H; Korff C; Ansari M; Catsman-Berrevoets C; von Bueren AO
    Cancer Rep (Hoboken); 2021 Oct; 4(5):e1383. PubMed ID: 33939330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities.
    Gojo J; Pavelka Z; Zapletalova D; Schmook MT; Mayr L; Madlener S; Kyr M; Vejmelkova K; Smrcka M; Czech T; Dorfer C; Skotakova J; Azizi AA; Chocholous M; Reisinger D; Lastovicka D; Valik D; Haberler C; Peyrl A; Noskova H; Pál K; Jezova M; Veselska R; Kozakova S; Slaby O; Slavc I; Sterba J
    Front Oncol; 2019; 9():1436. PubMed ID: 31998633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas.
    Gokce-Samar Z; Beuriat PA; Faure-Conter C; Carrie C; Chabaud S; Claude L; Di Rocco F; Mottolese C; Szathmari A; Chabert C; Frappaz D
    Childs Nerv Syst; 2016 Aug; 32(8):1415-23. PubMed ID: 27379495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.
    Hoffman LM; DeWire M; Ryall S; Buczkowicz P; Leach J; Miles L; Ramani A; Brudno M; Kumar SS; Drissi R; Dexheimer P; Salloum R; Chow L; Hummel T; Stevenson C; Lu QR; Jones B; Witte D; Aronow B; Hawkins CE; Fouladi M
    Acta Neuropathol Commun; 2016 Jan; 4():1. PubMed ID: 26727948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DIPG in Children - What Can We Learn from the Past?
    Vanan MI; Eisenstat DD
    Front Oncol; 2015; 5():237. PubMed ID: 26557503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Impact of Radiotherapy in Conjunction with Temozolomide in Diffuse Intrinsic Pontine Glioma: A Systematic Review and Meta-Analysis.
    Shi S; Lu S; Jing X; Liao J; Li Q
    World Neurosurg; 2021 Apr; 148():e565-e571. PubMed ID: 33476781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a human in vitro blood-brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance.
    Deligne C; Hachani J; Duban-Deweer S; Meignan S; Leblond P; Carcaboso AM; Sano Y; Shimizu F; Kanda T; Gosselet F; Dehouck MP; Mysiorek C
    Fluids Barriers CNS; 2020 Jun; 17(1):37. PubMed ID: 32487241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma.
    Muroi A; Mizumoto M; Ishikawa E; Ihara S; Fukushima H; Tsurubuchi T; Sakurai H; Matsumura A
    Childs Nerv Syst; 2020 Mar; 36(3):507-512. PubMed ID: 31728705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Radiation Therapy in the Management of Diffuse Intrinsic Pontine Glioma: A Systematic Review.
    Gallitto M; Lazarev S; Wasserman I; Stafford JM; Wolden SL; Terezakis SA; Bindra RS; Bakst RL
    Adv Radiat Oncol; 2019; 4(3):520-531. PubMed ID: 31360809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.